Vascular Biogenics Ltd. - Ordinary Shares (VBLT): Price and Financial Metrics
Vascular Biogenics Ltd. - Ordinary Shares (VBLT)
Today's Latest Price: $1.18 USD
0.07 (6.31%)
Updated Nov 21 6:55pm
Add VBLT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
VBLT Stock Summary
- For VBLT, its debt to operating expenses ratio is greater than that reported by just 0.39% of US equities we're observing.
- VBLT's price/sales ratio is 75.44; that's higher than the P/S ratio of 97.86% of US stocks.
- Revenue growth over the past 12 months for Vascular Biogenics Ltd comes in at -95.78%, a number that bests only 0.65% of the US stocks we're tracking.
- Stocks that are quantitatively similar to VBLT, based on their financial statements, market capitalization, and price volatility, are ASMB, OTIC, DCPH, EVGN, and MGEN.
- Visit VBLT's SEC page to see the company's official filings. To visit the company's web site, go to www.vblrx.com.
VBLT Daily Price Range
VBLT 52-Week Price Range
VBLT Stock Price Chart More Charts
VBLT Price/Volume Stats
| Current price | $1.18 |
| Prev. close | $1.11 |
| Day low | $1.10 |
| Day high | $1.18 |
| 50-day MA | $1.26 |
| 200-day MA | $1.32 |
| 52-week high | $1.90 |
| 52-week low | $0.60 |
| Volume | 83,600 |
| Avg. volume | 80,164 |
| Dividend yield | N/A |
| Market Cap | 42.34M |
Vascular Biogenics Ltd. - Ordinary Shares (VBLT) Company Bio
Vascular Biogenics Limited is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of treatments for cancer and immune-inflammatory diseases. The company was founded in 2000 and is based in Or Yehuda, Israel.
Top Stories View All
Best & Worst Performing Stock Industries for November 21, 2019
Best & Worst Performing Small Cap Stocks for November 21, 2019
Best & Worst Performing Mid Cap Stocks for November 21, 2019
Best & Worst Performing Large Cap Stocks for November 21, 2019
Best & Worst Performing Mega Cap Stocks for November 21, 2019
View All Top Stories
Loading social stream, please wait...